Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03322722
Other study ID # LAVOILACTEE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 14, 2016
Est. completion date December 7, 2022

Study information

Verified date April 2023
Source Groupe Hospitalier Paris Saint Joseph
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The alimentation of the premature newborn children is one of main thing concerning of nurses and pediatricians in neonatology. The absence of common tool of evaluation of the children cause a great discrepancy in prescriptions and the practices of the nursing.The aim of this study is to estimate the improvement of the food empowerment of the premature newborn children after the introduction of a help tool at the food progress which allows to fit the prescription of food(supply) to the capacities of the newborn child.


Description:

If the importance of feeding premature newborns is a central concern during their management, the absence of an evaluation tool leads to a great disparity in their implementation (particularly marked by at regular times by the care teams), which can eventually lead to oral disorders. The possibility of an assessment of the newborn's skills could allow a homogenization of therapeutic proposals and thus a potentially faster progression of dietary independence of the newborn. This method could also encourage parental involvement in feeding care. The objective of the study is to evaluate the impact of a tool to help food progression on food autonomy.


Recruitment information / eligibility

Status Completed
Enrollment 87
Est. completion date December 7, 2022
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 1 Day to 5 Days
Eligibility Inclusion Criteria: - born before 37 weeks of pregnancy - hospitalized in GHPSJ neonatology - Predictable duration of hospitalization of at least 7 days Exclusion Criteria: - parents not speaking french language - new borm with complication du to his prematurity

Study Design


Locations

Country Name City State
France Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Age of prematurity of the newborn child It's an estimation between the real age of the premature baby (i.e number of weeks of pregnancy) and the normal date of delivery. delivery date
See also
  Status Clinical Trial Phase
Completed NCT03513146 - Oropharyngeal Administration of Mother's Milk in Preterm Infants and Neonatal Infection N/A